We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Strep B Genome Yields Surprising Diversity

By Biotechdaily staff writers
Posted on 12 Sep 2002
Researchers have published the complete genome sequence for the pathogenic bacterium Streptococcus agalactiae (also known as group B streptococcus or strep B), which is a major cause of pneumonia and meningitis in newborns and the source of life-threatening illnesses in a growing number of adults with deficient immune systems. More...
The research was reported in the August 28, 2002, online edition of the Proceedings of the National Academy of Sciences.

As part of the study, investigators from The Institute for Genomic Research (Rockville, MD, USA; www.tigr.org) compared the genome of the ‘serotype V' isolate of S agalactiae--the most common capsule type that is associated with invasive infection among adults other than pregnant women--to the genetic makeup of other S agalactiae strains and also to two different species of streptococci (S pneumoniae and S pyogenes) that cause diseases in humans.

S agalactiae has a circular genome of about 2.16 million base pairs. Researchers predicted that there would be 2,176 genes in that genome, and about 65% of the proteins expressed by those genes were of known function. The authors of the current study found that the three streptococcal species shared 1,060 genes, about half of their genes, but that 683 genes were unique to S agalactiae.

"We were surprised to find so many differences among the isolates of this important pathogen, said the study's first author, Dr. Herve Tettelin, an associate investigator at The Institute for Genomic Research. "Those differences could help explain why some strains of S agalactiae are much more virulent than others.”

Dr. Tettelin said the microarray experiments that compared those related genomes found numerous differences, even among strains with the same serotype. For example variations exist in the type of polysaccharides that make up the capsule that surrounds each bacterium. Furthermore, the S agalactiae genome differed from that of other streptococci in several of the microbe's metabolic pathways and in related transport systems through the bacterium's cell membrane. The researchers also found unique genes in S agalactiae related to surface proteins, capsule synthesis, and the hemolysin enzyme.



Related Links:
The Institute for Genomic Research

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Automated Clinical Chemistry Analyzer
Envoy 500+
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.